Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Clean Power Hydrogen PLC ( (GB:CPH2) ) just unveiled an update.
Clean Power Hydrogen PLC has signed a non-binding memorandum of understanding with ABE Gruppe, a subsidiary of Swiss-listed BKW Infra Services Europa, to explore the supply, installation, commissioning and maintenance of 175MW of its membrane-free electrolysers over the next decade. The partnership aims to deploy CPH2’s technology across BKW and ABE markets in Germany, Switzerland and beyond, targeting renewable generators, industrial users and sectors such as life sciences, healthcare, mobility and data centres, supporting Germany’s National Hydrogen Strategy and potentially strengthening CPH2’s position in the growing decentralised green hydrogen market.
By leveraging BKW’s scale, infrastructure footprint and customer base, the collaboration is designed to monetise curtailed renewable energy and improve process efficiency in hydrogen and oxygen-intensive industries. The deal underscores growing market appetite for CPH2’s claimed lower lifetime cost, high-purity hydrogen and oxygen production, and, if converted into firm orders, could materially expand its installed base and recurring operations and maintenance revenues over time.
Spark’s Take on CPH2 Stock
According to Spark, TipRanks’ AI Analyst, CPH2 is a Neutral.
The score is held down primarily by very weak financial performance (near-zero revenue, widening losses, and significant cash burn with a sharply reduced equity base). Technicals are moderately supportive with an uptrend and positive momentum, but elevated RSI increases pullback risk. Valuation remains unattractive/unclear due to ongoing losses and no indicated dividend yield.
To see Spark’s full report on CPH2 stock, click here.
More about Clean Power Hydrogen PLC
Clean Power Hydrogen PLC, listed on London’s AIM market, develops membrane-free electrolyser technology for the co-production of high-purity hydrogen and above medical-grade oxygen. Its patent-protected systems target decentralised applications such as wastewater treatment, curtailed wind and solar capture, data centre backup, medical and life sciences, and heavy-duty mobility.
Average Trading Volume: 821,477
Technical Sentiment Signal: Buy
Current Market Cap: £50.2M
See more insights into CPH2 stock on TipRanks’ Stock Analysis page.

